Business Description

ADVANZ PHARMA, a worldwide pharmaceutical firm, is committed to providing improved access to niche-established medications to health care providers and patients all around the world. With sales in over 100 countries, the Company also has a diverse portfolio of more than 200 off-patent compounds that makes up over 1,300 SKUs. It also markets orphan drugs via its Orphan Drug Division.

This currently includes Photofrin, which is used to treat certain rare forms. The company is currently testing new indications. Advanz Pharma is a parent of Specialty Pharmaceutical Company Correvio Pharma Corp. The company was established in 2010 and has its headquarters in London, UK.

Key Financials

Revenue (US$ Mn):

• Advanz Pharma Corp. Ltd’s annual revenue for 2021 was US$ 526 Mn, a 3.4% increase from 2020
• The annual revenue generated by Advanz Pharma Corp. Ltd in 2020 was US$ 508 Mn
• At a -14.23% decrease, Advanz Pharma Corp. Ltd’s annual revenue of US$ 537 Mn was indexed in 2019
• Advanz Pharma Corp. Ltd generated total revenue of US$ 626 Mn in 2018

Operating Income (US$ Mn):

• US$ -5 Mn was Advanz Pharma Corp. Ltd’s operating income in 2021, a -96.21% decrease from 2020 figures
• Advanz Pharma Corp. Ltd indexed a -14.27% decrease in operating incomes from 2019, amounting to US$ -140 Mn in 2020
• Advanz Pharma Corp. Ltd generated an operating income of US$ -163 Mn in 2019
• An operating income of US$ -1,165 Mn was indexed by Advanz Pharma Corp. Ltd in 2018

Net Income (US$ Mn):

• US$ -75 Mn was the net income generated by Advanz Pharma Corp. Ltd in 2021
• Advanz Pharma Corp. Ltd’s net income for 2020 was US$ -196 Mn, a -113.36% decrease from 2019
• From 2018’s net incomes, Advanz Pharma Corp. Ltd registered a -192.24% decrease in 2019, amounting to US$ 1,467 Mn
• A net income of US$ -1,591 Mn was generated in 2018 by Advanz Pharma Corp. Ltd

Operating Margin %:

• Advanz Pharma Corp. Ltd’s operating margin for 2021 was -1%, a -96.36% decrease from 2020
• The operating margin generated by Advanz Pharma Corp. Ltd in 2020 was -28%
• At a -83.66% decrease, Advanz Pharma Corp. Ltd’s operating margin of -30% was indexed in 2019
• Advanz Pharma Corp. Ltd generated an operating margin of -186% in 2018

Gross Margin %:

• 63% was Advanz Pharma Corp. Ltd’s gross margin in 2021, a -4.37% decrease from 2020 figures
• Advanz Pharma Corp. Ltd indexed a -1.34% decrease in gross margins from 2019, amounting to 66% in 2020
• Advanz Pharma Corp. Ltd generated a gross margin of 67% in 2019
• A gross margin of 70% was indexed by Advanz Pharma Corp. Ltd in 2018

SWOT Analysis

Strengths

various revenue models

Over the years, Advanz Pharma has broadened its commercial operations beyond the healthcare industry. Due to this, the business has been able to diversify its revenue sources beyond the biotechnology industries and healthcare sector.

Get this premium content

The Premium data is Locked

Buy Now to Unlock Premium Data

Request Sample Data